One RCT of 102 women with PCOS compared myoinositol to metformin in GnRH antagonist cycles and reported no difference in the rates of OHSS, though confidence intervals were very wide (40). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.